Table 4 Unadjusted and adjusted all-cause mortality, hazard ratio (HR), 95% confidence interval (CI) and (p-value), for SARS-CoV-2 positive and SARS-CoV-2 negative patients
From: SARS-CoV-2 in dialysis patients and the impact of vaccination
Unadjusted Model | Univariable Model 1 | Univariable Model 2 | Univariable Model 3 | Univariable Model 4 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
(Age) | (Gender) | (Ethnicity) | (Dialysis location) | |||||||||
Cohort | HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | HR (95% CI) | p value | ||
SARS-CoV-2 –ve (n = 474) | 1.0 | - | 1.0 | - | 1.0 | - | 1.0 | - | 1.0 | - | ||
SARS-CoV-2 + ve (n = 188) | 1.81 (1.32–2.49) | < 0.001 | 1.88 (1.37–2.60) | < 0.001 | 1.82 (1.33–2.51) | < 0.001 | 1.81 (1.32–2.50) | < 0.001 | 1.83 (1.33–2.52) | < 0.001 | ||
Age | 10-year bands | 1.26 (1.13–1.42) | < 0.001 | |||||||||
Gender | Female (ref) | 1.07 (0.77–1.48) | 0.68 | |||||||||
Ethnicity | Non-Asian (ref) | 0.86 (0.41–1.85) | 0.71 | |||||||||
Dialysis location | Satellite (ref) | 2.36 (1.70–3.27) | < 0.001 | |||||||||